ESC 365 - Effect of PCSK9 inhibitors treatment on acute coronary syndrome and stroke incidence: a metanalysis of currently available clinical trials

ESC Premium Access

Effect of PCSK9 inhibitors treatment on acute coronary syndrome and stroke incidence: a metanalysis of currently available clinical trials

Session: Lipid modification for the 21st century

Topic: Drug therapy

Speaker: Doctor A. Cordero (Elche, ES)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Alberto Cordero

IMED Elche Hospital, Elche (Spain)

4 presentations

0 follower

4 more presentations in this session

State of the Art - The symphony of lipids in 2019

Speaker: Professor U. Laufs (Leipzig, DE)

Association between degree of LDL-cholesterol decrease after a myocardial infarction and mortality - a nationwide cohort study

Speaker: Doctor J. Schubert (Uppsala, SE)

Unmet need for secondary prevention in individuals from the general population with increased lipoprotein(a): a contemporary population-based study

Speaker: Doctor C. Madsen (Herlev, DK)

Novel biomarkers in the lipid area.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Access the full session

Lipid modification for the 21st century

Speakers: Doctor A. Cordero, Professor U. Laufs, Doctor J. Schubert, Doctor C. Madsen, Professor B. Nordestgaard

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources